Important note

For all questions concerning the treatment with a UCB medicine and its application please reach out to UCBCares®.

Information from UCBCares® does not replace the conversation or the medical advice of the treating doctor and is not meant to promote the medicines of UCB.

General Media Enquiries & UCB Headquarters

Laurent Schots
Phone: +32 2 559 92 64
E-mail: Laurent.Schots@ucb.com

France Communications

Thomas Lhernould
Phone: +33 1 47 29 44 09
E-mail: Thomas.Lhernould@ucb.com

US Communications

Erica Puntel
Phone:  +1 404 938 5355
E-mail: Erica.Puntel@ucb.com

UK Communications

Karen Borrer
Phone: +44 175 371 3006
E-mail: Karen.Borrer@ucb.com

Germany Communications

Werner Bleilevens
Phone: +49 2173 48 10 56
E-mail: Werner.Bleilevens@ucb.com

Italy Communications

Francesco Ricca
Phone: +39 02 30079 276
E-mail: Francesco.Ricca@ucb.com

Iberia Communications

Monica Lopez
Phone: +34 919 147761
Email: monica.lopez@ucb.com

Patients Solutions and Research & Development Communications

Scott Fleming
Phone: +44 175 344 7515
Email: Scott.Fleming@ucb.com

Patient Impact and Neurology Communications


Nick Francis
Phone: +44 175 380 7329
E-mail: Nick.Francis@ucb.com

Patient Evidence and Immunology Communications

Amy Cheshire
Phone: +44-175-344 3273
Email: amy.cheshire@ucb.com